Close Menu

NEW YORK — Japanese diagnostics firm Sysmex said on Wednesday that it has received Class III approval from China’s National Medical Products Administration for its Lynoamp BC in vitro diagnostic reagent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.